IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 214 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $57,000 | -10.9% | 5,562 | 0.0% | 0.00% | – |
| Q2 2022 | $64,000 | -14.7% | 5,562 | -7.4% | 0.00% | – |
| Q1 2022 | $75,000 | -59.0% | 6,008 | -61.8% | 0.00% | -100.0% |
| Q4 2021 | $183,000 | -95.4% | 15,729 | -94.8% | 0.00% | -93.3% |
| Q3 2021 | $3,976,000 | -53.8% | 304,857 | -54.4% | 0.02% | -53.1% |
| Q2 2021 | $8,599,000 | +242.5% | 668,161 | +197.4% | 0.03% | +220.0% |
| Q1 2021 | $2,511,000 | -67.8% | 224,636 | -67.2% | 0.01% | -66.7% |
| Q4 2020 | $7,800,000 | +8.9% | 684,891 | -13.9% | 0.03% | 0.0% |
| Q3 2020 | $7,160,000 | +34.9% | 795,804 | +54.7% | 0.03% | +30.4% |
| Q2 2020 | $5,308,000 | +26440.0% | 514,332 | +26289.5% | 0.02% | – |
| Q1 2020 | $20,000 | – | 1,949 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |